1. Home
  2. CCRN vs RLAY Comparison

CCRN vs RLAY Comparison

Compare CCRN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRN
  • RLAY
  • Stock Information
  • Founded
  • CCRN 1986
  • RLAY 2015
  • Country
  • CCRN United States
  • RLAY United States
  • Employees
  • CCRN N/A
  • RLAY N/A
  • Industry
  • CCRN Professional Services
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CCRN Consumer Discretionary
  • RLAY Health Care
  • Exchange
  • CCRN Nasdaq
  • RLAY Nasdaq
  • Market Cap
  • CCRN 447.2M
  • RLAY 490.3M
  • IPO Year
  • CCRN N/A
  • RLAY 2020
  • Fundamental
  • Price
  • CCRN $13.23
  • RLAY $3.15
  • Analyst Decision
  • CCRN Hold
  • RLAY Strong Buy
  • Analyst Count
  • CCRN 5
  • RLAY 11
  • Target Price
  • CCRN $17.93
  • RLAY $18.40
  • AVG Volume (30 Days)
  • CCRN 248.8K
  • RLAY 2.2M
  • Earning Date
  • CCRN 05-07-2025
  • RLAY 05-05-2025
  • Dividend Yield
  • CCRN N/A
  • RLAY N/A
  • EPS Growth
  • CCRN N/A
  • RLAY N/A
  • EPS
  • CCRN N/A
  • RLAY N/A
  • Revenue
  • CCRN $1,258,238,000.00
  • RLAY $7,679,000.00
  • Revenue This Year
  • CCRN N/A
  • RLAY N/A
  • Revenue Next Year
  • CCRN $5.37
  • RLAY $169.23
  • P/E Ratio
  • CCRN N/A
  • RLAY N/A
  • Revenue Growth
  • CCRN N/A
  • RLAY N/A
  • 52 Week Low
  • CCRN $9.58
  • RLAY $1.78
  • 52 Week High
  • CCRN $18.50
  • RLAY $10.72
  • Technical
  • Relative Strength Index (RSI)
  • CCRN 22.64
  • RLAY 50.08
  • Support Level
  • CCRN $13.81
  • RLAY $2.75
  • Resistance Level
  • CCRN $13.96
  • RLAY $3.10
  • Average True Range (ATR)
  • CCRN 0.32
  • RLAY 0.20
  • MACD
  • CCRN -0.03
  • RLAY 0.01
  • Stochastic Oscillator
  • CCRN 1.18
  • RLAY 58.16

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: